Life Science Investing Journey Medical Corporation Announces Publication of Clinical Trial Results Assessing the Impact of Emrosi on Microbial Flora of Healthy Adults in the Journal of Drugs in Dermatology
Life Science Investing Journey Medical Corporation Reports Third Quarter 2025 Financial Results and Recent Corporate Highlights
Life Science Investing Journey Medical Corporation to Announce Third Quarter 2025 Financial Results on November 12, 2025
Life Science Investing Journey Medical Corporation Reports Combined Emrosi Phase 3 Clinical Trial Efficacy Data Analysis Presented at the 2025 Fall Clinical Dermatology Conference
Life Science Investing Journey Medical Corporation to Participate in October 2025 Investor Conferences
Life Science Investing Journey Medical Corporation to Participate in September 2025 Investor Conferences
Angkor Resources Advances Exploration On CZ Gold And Wild Boar Prospects, Andong Meas License, Cambodia
Freegold Drills 1.28 g/t Au over 49.3m in New Tamarack Zone at Golden Summit and 0.91 g/t Au Over 150.9m at Cleary
Rio Silver Provides Shareholders With a Five-Step Plan to Access High-Grade Surface Silver and Advance Toward Near-Term Production at Maria Norte
